Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals.
about
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicinesA gap between acceptance and knowledge of herbal remedies by physicians: the need for educational intervention.Potential for drug interactions in seniors with osteoarthritisDrug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypesThe potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products.Review of the regulations for clinical research in herbal medicines in USA.Reducing drug-herb interaction risk with a computerized reminder system.Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo bilobaEffect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humansAssessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.Herb-drug interactions: an overview of the clinical evidence.Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules.Community Pharmacists' Views and Practices Regarding Natural Health Products Sold in Community PharmaciesNatural health product interactions with medication.Managing osteoarthritis. Medication use among seniors in the communityPotential effects of herbal medicines and nutritional supplements on coagulation in ENT practice.Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance.Medication use by middle-aged and older participants of an exercise study: results from the Brain in Motion study.Identification and evaluation of drug-supplement interactions in Hungarian hospital patients.Intra-herb pharmacokinetics interaction between quercetin and isorhamentin.Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MSInhibitory effect of mitragynine on human cytochrome P450 enzyme activities.Self-medication with nutritional supplements and herbal over-thecounter products.Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats.Pharmacokinetics, tissue distribution and excretion study of a furostanol glycoside-based standardized fenugreek seed extract in rats.Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.Potential interactions between pharmaceuticals and natural health products in Canada.Perceptions of natural health products among patients attending a memory clinic.Adverse Drug Events in Cognitively Impaired Elderly Patients
P2860
Q21090750-85833BE7-DF28-4944-A343-E04126311C33Q24816269-8D0ADADF-645F-4A1B-931B-49C74C0CE2A2Q28200227-EDF055A9-DAB2-4A5F-805F-8A55C48D4D94Q33509452-0820EE3B-B8C3-4FD1-A3AD-5DBC65B1BAE3Q34419646-3497447D-7BC4-4844-B118-8BBE14147582Q34432298-3A944998-1D37-47DD-A77B-C75DFCFB1386Q34449725-C22F894B-B808-4B43-9C61-BA1675618B9AQ35111490-7C6C849D-19A0-426F-9040-C740ED89B2DAQ35725540-E3EB41BC-7582-42A8-8EA6-9462211EA33EQ35765836-6B771BB4-6BC5-4ED7-BD65-520904BDB58AQ35781981-E350FCFC-5FD3-40CD-B0B7-36515A26A526Q35781985-BFA2B0A3-9EAF-42D1-9EA4-A826AA449C3CQ35792862-6FFE78E2-5738-4D56-AD7B-4555F0999161Q36014951-2C3AC42F-18AF-4308-B7AF-DEDC73290075Q36040772-0983DA64-B599-44A1-873F-AA93AC8B7726Q36142607-29461B61-B5EA-4F0C-940F-8042FE265FA3Q36278312-A4A5410F-DF37-4135-8BE0-F9C082C54049Q36406732-510FFC2C-79AC-4D70-815A-90BD2E8F16C0Q36886357-99D7A2A4-5256-4D74-A624-BAA0EFCC28A7Q36926307-DC719748-6AC9-406D-AA8C-9AD122C471A5Q37481442-F52428D8-89F2-4315-93A2-E80FA1D1DF56Q37637048-CCC51EE1-3789-481A-9961-B4D64124F77FQ38190455-987A1675-8FDA-4F81-8C15-C87E9CDF63F0Q39924679-E6242F65-5A43-43CD-9615-EE8CCAAF8D9DQ41487258-5E0AFBFC-C7CB-47DC-8DB7-98A9925169C0Q42934962-1573999C-FBF7-41E3-99D1-7FCF85EE81E7Q46096628-AAACD512-09A1-4469-ABBA-624A9885CDB0Q47851974-746F7D86-E8DA-421A-B747-9CDAF605AC70Q48113688-9E3433E1-CD5B-4284-A1CF-8A91A5A0617DQ48598672-5630F066-4E30-4695-B3F6-A8149AAB4DC8Q48651682-01BBD224-41DB-4838-A6E0-4CB816869741Q51769539-B768286E-5F7A-45A8-9B57-9E2F4C07F1E8Q51980689-3B329DA4-365C-45F4-9A65-7D72F03C502AQ57271967-BA7548CA-7992-4D24-B187-B5CCB7A1CB07
P2860
Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Drug-herb interaction among co ...... for health care professionals.
@ast
Drug-herb interaction among co ...... for health care professionals.
@en
type
label
Drug-herb interaction among co ...... for health care professionals.
@ast
Drug-herb interaction among co ...... for health care professionals.
@en
prefLabel
Drug-herb interaction among co ...... for health care professionals.
@ast
Drug-herb interaction among co ...... for health care professionals.
@en
P1476
Drug-herb interaction among co ...... for health care professionals.
@en
P2093
Mitchell A H Levine
Nicole C Brazier
P304
P356
10.1097/00045391-200305000-00003
P577
2003-05-01T00:00:00Z